Back to Search

CODX

Co-Diagnostics, Inc. Common Stock
Data: 2026-01-13
$2.36
Price
-60.54%
Change
$6.35
52W High
$0.1657
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Quick Stats

53.5

AI Score

HOLD

1.01

Volume Ratio

Next Earnings

11

+ve Days (30d)

19

-ve Days (30d)

CODX Stock Summary

Last updated

CODX is currently trading at $2.36, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $0.1657 to $6.35.

Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CODX at 53.5/100 with a HOLD recommendation.

CODX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CODX Price vs Max Options Open Interest
CODX Max Change In Options Open Interest

CODX Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CODX Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CODX Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CODX Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Co-Diagnostics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

CODX Moving Averages Analysis

CODX (Co-Diagnostics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated

Days MA

CODX Fundamental Analysis

P/E (Forward) 16
P/E (Trailing) --
Market Cap ($) 12.5 million
Earnings/Share ($) -29.4
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -21
EPS Estimate Next Year ($) -12.15
WallStreet Target Price ($) 45.0001
Most Recent Quarter